A
Adverum Biotechnologies D
D
ADVM
4.10000
USD
-0.07
(-1.75%)
مغلق
حجم التداول
351,859
الربح لكل سهم
-7
العائد الربحي
-
P/E
-1
حجم السوق
86,035,060
الأخبار المقالات
العنوان: Adverum Biotechnologies
القطاع: Healthcare
الصناعة: Biotechnology
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.